Department of Cardiovascular Surgery, Faculty of Medicine, Bezmialem Vakif University, İstanbul, Turkey.
Department of Cardiology, Başaksehir Çam and Sakura City Hospital, İstanbul, Turkey.
Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1). doi: 10.1093/icvts/ivac049.
This study presents the mid-term results of a novel tricuspid valve (TV) repair strategy defined as 'mitralization of TV' (resection and plication of the posterior leaflet, ring implantation, optional leaflet procedures) applied for the correction of tricuspid regurgitation (TR).
Between 2017 and 2020, a total of 22 patients underwent concomitant TV repair using mitralization of the TV. Fourteen of the patients had functional TR (2 of them had severe tethering), 5 patients had prolapse and 3 patients had rheumatic involvement.
There was no in-hospital mortality. Moderate or severe TR was not observed in any patient in echocardiographic evaluations before discharge. The mean follow-up duration was 30.9 + 6.2 months. Moderate-to-severe TR-free survival was 100% in the second year and 94.7% in the third year.
Mitralization of the TV is a safe and effective treatment modality in terms of its mid-term results. This new technique provides an innovative perspective for the treatment of TR, especially in complex TV pathologies.
本研究介绍了一种新型三尖瓣（TV）修复策略的中期结果，该策略定义为“TV 二尖瓣化”（后瓣切除和折叠、环植入、可选瓣叶手术），用于纠正三尖瓣反流（TR）。
2017 年至 2020 年，共有 22 例患者接受了 TV 修复手术，采用二尖瓣化 TV 修复。其中 14 例患者为功能性 TR（其中 2 例存在严重牵拉），5 例患者为脱垂，3 例患者为风湿性累及。
无院内死亡。在出院前的超声心动图评估中，无患者出现中度或重度 TR。平均随访时间为 30.9 ± 6.2 个月。第二年和第三年中度至重度 TR 无复发生存率均为 100%。
就中期结果而言，TV 二尖瓣化是一种安全有效的治疗方法。这项新技术为 TR 的治疗提供了一个创新的视角，特别是在复杂的 TV 病变中。
